Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.86 USD | +8.73% | +10.29% | +47.89% |
Apr. 11 | Summit Therapeutics Inc. Appoints Dr. Mostafa Ronaghi to Its Board of Directors | CI |
Apr. 09 | Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed | RE |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.18B 2.72B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 105 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 11.89% |
Latest transcript on Summit Therapeutics Inc.
1 day | +8.73% | ||
1 week | +10.29% | ||
Current month | -6.76% | ||
1 month | +2.93% | ||
3 months | -0.52% | ||
6 months | +113.26% | ||
Current year | +47.89% |
Managers | Title | Age | Since |
---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 20-11-10 |
Robert Duggan
CEO | Chief Executive Officer | 79 | 19-11-30 |
Director of Finance/CFO | 46 | 19-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Duggan
CEO | Chief Executive Officer | 79 | 19-11-30 |
Robert Booth
BRD | Director/Board Member | 70 | 22-09-27 |
Director of Finance/CFO | 46 | 19-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 3.86 | +8.73% | 1,389,104 |
24-04-25 | 3.55 | -1.11% | 1,407,270 |
24-04-24 | 3.59 | -3.75% | 1,282,702 |
24-04-23 | 3.73 | +6.88% | 1,754,697 |
24-04-22 | 3.49 | -0.29% | 1,238,030 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+47.89% | 2.71B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- SMMT Stock